ClinicalTrials.gg
CompletedNCT03491787Updated May 16, 2025

Ultrasound-guidance for Intraosseous Access During Earthquake

An observational study in Cardiac Arrest Due to Trauma (Disorder), sponsored by San Salvatore Hospital of L'Aquila. Completed. Per ClinicalTrials.gov, last updated 2025-05-16.

Sponsored by San Salvatore Hospital of L'Aquila · Observational

Study type
Observational
Model
Case-control
Time perspective
Retrospective
Enrollment
31
Sex
All
01

Study summary

The aim of this field report is to describe as the use ultrasound guidance can facilitate the insertion of intraosseous access, during the resuscitation, in the victims of out-of hospital traumatic cardiac arrest

Read the detailed description

The aim of this field report is to describe as the use ultrasound guidance can facilitate the insertion of intraosseous access, decreasing the time for drug administration and providing some benefits during the resuscitation, in the victims of out-of hospital traumatic cardiac arrest.

02

Conditions studied

  • Cardiac Arrest Due to Trauma (Disorder)

Browse trials for

03

In context

Heart Arrest

926 studies on the registry are indexed under Heart Arrest; 226 are open to participants now.

This study's enrollment of 31 is below the median of 200 across 376 observational studies indexed under Heart Arrest.

Browse Heart Arrest studies →

Lead sponsor

San Salvatore Hospital of L'Aquila is the lead sponsor of 12 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

People under the rubble, after the earthquake

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • traumatic cardiac arrest

Exclusion criteria

Exclusion Criteria:

  • non traumatic cardiac arrest
  • beheading
  • post-mortem hypostasis
  • carbonized bodies
  • dismembered bodies
05

Study design

Observational model
Case-control
Time perspective
Retrospective
Enrollment
31 participants (actual)
Patient registry
No

Groups and cohorts

  • Ultrasound guidance

    The ultrasound guidance was used to establish intraosseous access

    Device: Ultrasound guidance

  • Not ultrasound guidance

    The ultrasound guidance was not used to obtain intraosseous access

Interventions

  • DeviceUltrasound guidance

    The ultrasound guidance was used to obtain intraosseous access

06

What researchers measure

Primary outcomes

  1. Intraosseus access

    The time used to esteblish the intraosseus access

    Time frame: up to 10 minutes

Secondary outcomes

  1. Return of spontaneous circulation

    The time to obtain the return of spontaneous circulation

    Time frame: up to 1 hour

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 16, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03491787
Lead sponsor
San Salvatore Hospital of L'Aquila
Responsible party
Emiliano Petrucci (Medical Doctor of Anesthesia and Intensive Care Unit, San Salvatore Hospital of L'Aquila) — Principal investigator
First posted
Apr 9, 2018
Start date
Sep 26, 2016
Primary completion
Nov 2016
Completion
Dec 2016
Last update
May 16, 2025

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion